Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTristel Regulatory News (TSTL)

Share Price Information for Tristel (TSTL)

Share Price is delayed by 15 minutes
Get Live Data
397.50    4.00 (1.03%)
Bid:
390.00
Ask:
405.00
Spread: 15.00 (3.846%)
Market Cap: £189.11m
TSTL Live PriceLast checked at - London Stock Exchange

Intraday Tristel Share Chart

Directorate Change

2 Jun 2010 07:00

RNS Number : 9010M
Tristel PLC
02 June 2010
 



 

("Tristel" or the "Company")

AIM: TSTL

 

Board Changes

 

Tristel plc, the AIM listed provider of infection and contamination control products, announces the appointment of Elizabeth Dixon as finance director. Ms Dixon replaces Paul Barnes who has been part-time group finance director since before the Company's flotation in June 2005. Mr Barnes continues on the Board as non-executive chairman of the Audit Committee. 

 

Ms Dixon, aged 40, is an experienced financial and management accountant having held senior finance roles for the past 10 years. She has acted as Tristel's group chief accountant since July 2007 and was appointed as finance director of the main trading subsidiary Tristel Solutions Limited in August 2009.

 

Ms Dixon is currently interested in 1,009 Ordinary 1p Shares, representing less than 1 per cent of the Company's issued share capital. In addition she holds options over 120,000 ordinary shares of 1p each in the Company ("Shares") under the Tristel plc Enterprise Management Incentive Scheme 2005 (the "Scheme"). 45,000 of these options are currently exercisable at 53.75p per share, further tranches of 15,000 options are exercisable at 53.75p on each of the following dates, 23rd July 2010, 4th August 2010, 23rd July 2011, 4th August 2011 and 4th August 2012

 

Pursuant to Rule 17, Schedule Two (g) of the AIM Rules for Companies the following information is disclosed:

 

Current Appointments of Elizabeth Dixon

Tristel Solutions Limited

 

Previous Appointments

None

 

ENDS

 

For further information, please contact:

Tristel PLC

 

Paul Swinney, Chief Executive

Tel: 01638 721 500

 

 

Walbrook PR Ltd

Tel: 020 7933 8787

Paul McManus

Mob: 07980 541 893

 

paul.mcmanus@walbrookpr.com

 

 

FinnCap

 

Geoff Nash/Rhydian Bankes (Corporate Finance)

Tel: 020 7600 1658

Simon Starr (Corporate Broking)

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAEAXKFELLEEFF
Date   Source Headline
23rd Apr 20187:00 amRNSEPA approval received
13th Apr 20182:55 pmRNSIssue of Equity
27th Mar 20188:19 amRNSIssue of Equity
26th Mar 20187:00 amRNSCommercial collaboration with Parker Laboratories
8th Mar 201810:58 amRNSIssue of Equity
20th Feb 20187:00 amRNSHalf-year Report
8th Feb 20182:19 pmRNSHolding(s) in Company
26th Jan 20187:00 amRNSIssue of Equity
24th Jan 20187:00 amRNSStudy shows comparable efficacy of Tristel Wipes
17th Jan 20187:00 amRNSInvestor results presentation
12th Dec 20172:57 pmRNSResult of AGM
12th Dec 20177:00 amRNSAGM Statement & notice of results
27th Nov 201710:35 amRNSIssue of Equity
23rd Nov 20173:24 pmRNSClarification of AGM timing
14th Nov 201710:34 amRNSIssue of Equity
2nd Nov 20177:00 amRNSDirectors dealing/grant of options
23rd Oct 20174:41 pmRNSIssue of Equity
19th Oct 20177:01 amRNSDirector Appointment
19th Oct 20177:00 amRNSFinal Results
3rd Oct 20177:00 amRNSTiming of EPA approval
19th Sep 20177:00 amRNSInvestor results presentation
18th Sep 20171:44 pmRNSIssue of Equity
22nd Aug 201712:08 pmRNSIssue of Equity
18th Aug 20171:31 pmRNSDirector/PDMR Dealing - replacement
17th Aug 20177:00 amRNSDirector/PDMR Dealing
7th Aug 20172:29 pmRNSIssue of Equity
24th Jul 20179:46 amRNSIssue of Equity
19th Jul 20177:00 amRNSTrading update & Notice of results
5th Jul 20177:00 amRNSIssue of Equity
3rd Jul 20171:59 pmRNSStrategic investment
3rd Jul 20177:00 amRNSSubmission to EPA & subsidiary incorporated in USA
13th Jun 20177:00 amRNSIssue of Equity
24th May 20177:00 amRNSShareholder Open Day & Notice of Trading Update
19th May 20173:34 pmRNSIssue of Equity
3rd May 20178:27 amRNSIssue of Equity
7th Apr 20175:04 pmRNSResult of Placing
7th Apr 20172:07 pmRNSProposed Secondary Placing
28th Mar 20172:38 pmRNSIssue of Equity
7th Mar 20179:41 amRNSIssue of Equity
6th Mar 20177:00 amRNSIssue of Equity
27th Feb 20177:00 amRNSProducts approved by Australia's TGA
27th Feb 20177:00 amRNSJournal of Ultrasound in Medicine & Biology
23rd Feb 20177:00 amRNSHalf-year Report
25th Jan 20177:00 amRNSInvestor results presentation
24th Jan 20177:00 amRNSJournal of Infection Prevention: TSTL wipes study
17th Jan 201712:31 pmRNSDirector / PDMR Shareholding
13th Dec 201612:30 pmRNSResult of AGM
13th Dec 20167:00 amRNSAGM Statement
6th Dec 20167:00 amRNSIssue of Equity
28th Nov 20163:42 pmRNSNotice of AGM correction

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.